This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Prudent Investors are Retaining Allstate (ALL) Stock Now
by Zacks Equity Research
Allstate's (ALL) expanding Protection Services segment is likely to drive its business growth.
Lemonade (LMND) Recently Broke Out Above the 200-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
Marsh & McLennan's (MMC) Guy Carpenter to Acquire Re Solutions
by Zacks Equity Research
The acquisition is anticipated to boost demand for Marsh & McLennan's (MMC) business Guy Carpenter's insurtech expertise in the Israeli market.
ProAssurance (PRA) Suspends Quarterly Dividends: Here's Why
by Zacks Equity Research
With the suspension of the quarterly dividends, ProAssurance (PRA) plans to focus on its existing share buyback program.
Wall Street Analysts See a 31.99% Upside in Lemonade (LMND): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Lemonade (LMND) points to a 32% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Equitable Holdings' (EQH) Board Okays New 10% Dividend Hike
by Zacks Equity Research
Equitable Holdings' (EQH) strong financial position with a bright future ahead enables it to take such investor-friendly measures.
Here's Why You Should Retain ProAssurance (PRA) Stock Now
by Zacks Equity Research
ProAssurance's (PRA) declining costs, high dividend yield and growing net investment income are major upsides.
eHealth (EHTH) Targets 8-10% Adjusted EBITDA Margin by 2025
by Zacks Equity Research
By the trailing 12-month period ending March 2025, eHealth (EHTH) expects to enter the positive operating cash flow region.
Here's Why Hold Strategy is Apt for Synchrony (SYF) Stock Now
by Zacks Equity Research
Synchrony (SYF) expects total loan receivables growth to be more than 10% for 2023.
Why Hold Strategy is Apt for American Express (AXP) Stock
by Zacks Equity Research
Higher loan volumes are likely to keep boosting American Express' (AXP) U.S. Consumer Services segment.
Rithm Capital (RITM) Reaches 10-Year Mark, $32B in Assets
by Zacks Equity Research
To date, Rithm Capital's (RITM) dividends paid reach around $4.6 billion.
Why Prudent Investors Are Adding AIG to Their Portfolio Now
by Zacks Equity Research
American International (AIG) rewards its shareholders with $603 million in repurchases and dividends worth $241 million in 1Q23.
Wall Street Analysts Think Lemonade (LMND) Could Surge 51.23%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 51.2% upside potential for Lemonade (LMND). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Is ING Group (ING) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how ING Groep (ING) and Lemonade (LMND) have performed compared to their sector so far this year.
Compared to Estimates, Lemonade (LMND) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Lemonade (LMND) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Lemonade (LMND) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 16.67% and 7.72%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Old Republic International (ORI) Q1 Earnings Top Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 22% and 2.57%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
American Express (AXP) Misses on Q1 Earnings, Reaffirms View
by Zacks Equity Research
Higher operating and customer engagement costs affect American Express' (AXP) first-quarter earnings.
Is AssetMark Financial (AMK) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how AssetMark Financial (AMK) and Lemonade (LMND) have performed compared to their sector so far this year.
Here's Why You Should Add Lemonade (LMND) to Your Kitty
by Zacks Equity Research
Lemonade (LMND) stands to gain from improvement in premium per customer, continued shift in the mix of underlying products toward higher value policies and higher instalment fees.
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Down -20.87% in 4 Weeks, Here's Why You Should You Buy the Dip in Lemonade (LMND)
by Zacks Equity Research
Lemonade (LMND) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Here's Why You Should Hold Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) benefits from higher premiums, strategic acquisitions, favorable underwriting and effective capital deployment.
Here's Why You Should Hold On to Radian Group (RDN) Stock
by Zacks Equity Research
Radian Group (RDN) is well-poised to grow, driven by higher persistency, strong-performing real estate services and a strong capital position.
Wall Street Analysts Believe Lemonade (LMND) Could Rally 40.28%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 40.3% in Lemonade (LMND). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.